25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CAPR (Capricor) Stock Analysis
Buy, Hold or Sell?

Let's analyze Capricor together

I guess you are interested in Capricor Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Capricor’s Financial Insights
  • 📈 Technical Analysis (TA) – Capricor’s Price Targets

I'm going to help you getting a better view of Capricor Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Capricor Therapeutics Inc

I send you an email if I find something interesting about Capricor Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Capricor (30 sec.)










1.2. What can you expect buying and holding a share of Capricor? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.79
Expected worth in 1 year
$5.18
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$2.39
Return On Investment
23.3%

For what price can you sell your share?

Current Price per Share
$10.25
Expected price per share
$6.15 - $16.17
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Capricor (5 min.)




Live pricePrice per Share (EOD)
$10.25
Intrinsic Value Per Share
$-36.99 - $-6.32
Total Value Per Share
$-34.20 - $-3.53

2.2. Growth of Capricor (5 min.)




Is Capricor growing?

Current yearPrevious yearGrowGrow %
How rich?$127.6m$10.4m$77.7m88.1%

How much money is Capricor making?

Current yearPrevious yearGrowGrow %
Making money-$13.7m-$6m-$7.6m-55.8%
Net Profit Margin-224.0%-124.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Capricor (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#310 / 884

Most Revenue
#366 / 884

Most Profit
#584 / 884

Most Efficient
#594 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Capricor?

Welcome investor! Capricor's management wants to use your money to grow the business. In return you get a share of Capricor.

First you should know what it really means to hold a share of Capricor. And how you can make/lose money.

Speculation

The Price per Share of Capricor is $10.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Capricor.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Capricor, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.79. Based on the TTM, the Book Value Change Per Share is $0.60 per quarter. Based on the YOY, the Book Value Change Per Share is $0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Capricor.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.53-5.2%-0.30-2.9%-0.13-1.3%-0.20-1.9%-0.16-1.6%-0.11-1.1%
Usd Book Value Change Per Share-0.39-3.8%0.605.8%0.070.7%0.191.8%0.131.3%0.070.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.39-3.8%0.605.8%0.070.7%0.191.8%0.131.3%0.070.6%
Usd Price Per Share9.49-10.82-4.97-6.73-5.71-4.04-
Price to Earnings Ratio-4.45--11.35--23.70--14.04--12.66--10.71-
Price-to-Total Gains Ratio-24.35--8.84--40.70--32.60--34.54--81.76-
Price to Book Ratio3.40-9.22-4.82-10.71-8.86-78.33-
Price-to-Total Gains Ratio-24.35--8.84--40.70--32.60--34.54--81.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.25
Number of shares97
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.600.13
Usd Total Gains Per Share0.600.13
Gains per Quarter (97 shares)57.9412.53
Gains per Year (97 shares)231.7650.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1023222205040
20464454010090
306956860150140
409279180200190
50115911500251240
60139113820301290
70162216140351340
80185418460401390
90208620780451440
100231823100501490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.092.00.02.1%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%13.027.00.032.5%23.071.00.024.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.094.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%6.014.00.030.0%13.027.00.032.5%23.071.00.024.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Capricor Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3900.597-165%0.067-683%0.188-308%0.129-402%0.066-692%
Book Value Per Share--2.7931.930+45%0.230+1116%0.815+243%0.765+265%0.408+584%
Current Ratio--6.5484.970+32%1.300+404%2.741+139%6.444+2%5.882+11%
Debt To Asset Ratio--0.1700.320-47%0.808-79%0.629-73%0.469-64%0.636-73%
Debt To Equity Ratio--0.2050.767-73%4.782-96%3.143-93%2.041-90%14.008-99%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--552423912.000571489844.000-3%226257097.500+144%334574436.333+65%288748909.300+91%198756773.318+178%
Eps---0.534-0.301-44%-0.133-75%-0.198-63%-0.162-70%-0.109-80%
Ev To Ebitda Ratio---5.619-12.830+128%-19.727+251%-13.250+136%-12.752+127%-10.881+94%
Free Cash Flow Per Share---0.166-0.258+56%-0.182+10%-0.180+9%-0.112-32%-0.125-25%
Free Cash Flow To Equity Per Share---0.1650.565-129%-0.030-82%0.154-207%0.142-216%11.878-101%
Gross Profit Margin--1.000282.213-100%104.863-99%129.359-99%78.015-99%39.508-97%
Intrinsic Value_10Y_max---6.322----------
Intrinsic Value_10Y_min---36.991----------
Intrinsic Value_1Y_max---0.519----------
Intrinsic Value_1Y_min---1.235----------
Intrinsic Value_3Y_max---1.647----------
Intrinsic Value_3Y_min---5.873----------
Intrinsic Value_5Y_max---2.879----------
Intrinsic Value_5Y_min---12.846----------
Market Cap468504950.000+7%433767022.000494444126.500-12%227167766.000+91%307461134.667+41%260968684.100+66%184776523.968+135%
Net Profit Margin----2.2400%-1.2430%-2.3820%-27.6040%-16.6370%
Operating Margin----2.3410%-1.3210%-2.4880%-27.7790%-16.7110%
Operating Ratio----246.5900%2.372-100%-79.6500%-6.6300%3.527-100%
Pb Ratio3.670+7%3.3989.218-63%4.819-29%10.708-68%8.856-62%78.327-96%
Pe Ratio-4.802-8%-4.446-11.350+155%-23.696+433%-14.039+216%-12.656+185%-10.708+141%
Price Per Share10.250+7%9.49010.818-12%4.970+91%6.727+41%5.710+66%4.043+135%
Price To Free Cash Flow Ratio-15.465-8%-14.318-10.933-24%-13.621-5%-8.887-38%-10.202-29%-9.998-30%
Price To Total Gains Ratio-26.296-8%-24.346-8.844-64%-40.697+67%-32.601+34%-34.539+42%-81.755+236%
Quick Ratio--11.6778.301+41%2.138+446%4.598+154%7.507+56%7.359+59%
Return On Assets---0.159-0.156-2%-0.136-14%-0.142-10%-0.131-17%-0.159+0%
Return On Equity---0.191-0.345+81%-0.816+327%-0.612+220%-0.432+126%-3.069+1506%
Total Gains Per Share---0.3900.597-165%0.067-683%0.188-308%0.129-402%0.066-692%
Usd Book Value--127645467.00088218767.000+45%10494978.000+1116%37250234.167+243%34988599.200+265%18652837.325+584%
Usd Book Value Change Per Share---0.3900.597-165%0.067-683%0.188-308%0.129-402%0.066-692%
Usd Book Value Per Share--2.7931.930+45%0.230+1116%0.815+243%0.765+265%0.408+584%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--552423912.000571489844.000-3%226257097.500+144%334574436.333+65%288748909.300+91%198756773.318+178%
Usd Eps---0.534-0.301-44%-0.133-75%-0.198-63%-0.162-70%-0.109-80%
Usd Free Cash Flow---7573806.000-11793941.500+56%-8333451.500+10%-8218075.083+9%-5129278.000-32%-5699086.925-25%
Usd Free Cash Flow Per Share---0.166-0.258+56%-0.182+10%-0.180+9%-0.112-32%-0.125-25%
Usd Free Cash Flow To Equity Per Share---0.1650.565-129%-0.030-82%0.154-207%0.142-216%11.878-101%
Usd Market Cap468504950.000+7%433767022.000494444126.500-12%227167766.000+91%307461134.667+41%260968684.100+66%184776523.968+135%
Usd Price Per Share10.250+7%9.49010.818-12%4.970+91%6.727+41%5.710+66%4.043+135%
Usd Profit---24392000.000-13766500.000-44%-6078500.000-75%-9029083.333-63%-7388100.000-70%-4960900.000-80%
Usd Revenue---4341000.000-100%6774500.000-100%4166741.917-100%14751173.000-100%7661908.950-100%
Usd Total Gains Per Share---0.3900.597-165%0.067-683%0.188-308%0.129-402%0.066-692%
 EOD+5 -3MRQTTM+15 -19YOY+21 -143Y+20 -145Y+17 -1710Y+19 -16

3.3 Fundamental Score

Let's check the fundamental score of Capricor Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.802
Price to Book Ratio (EOD)Between0-13.670
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than111.677
Current Ratio (MRQ)Greater than16.548
Debt to Asset Ratio (MRQ)Less than10.170
Debt to Equity Ratio (MRQ)Less than10.205
Return on Equity (MRQ)Greater than0.15-0.191
Return on Assets (MRQ)Greater than0.05-0.159
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Capricor Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.851
Ma 20Greater thanMa 5011.326
Ma 50Greater thanMa 10010.719
Ma 100Greater thanMa 20011.606
OpenGreater thanClose10.140
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Capricor Therapeutics Inc

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; and CAP-2003, and allogeneic cardiosphere-derived cells-exosomes, which is in preclinical trial to treat DMD. It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2025-06-19 01:51:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Capricor earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Capricor Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-224.0%+224.0%
TTM-224.0%YOY-124.3%-99.7%
TTM-224.0%5Y-2,760.4%+2,536.4%
5Y-2,760.4%10Y-1,663.7%-1,096.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM-224.0%-141.4%-82.6%
YOY-124.3%-186.1%+61.8%
3Y-238.2%-248.3%+10.1%
5Y-2,760.4%-338.6%-2,421.8%
10Y-1,663.7%-488.9%-1,174.8%
4.3.1.2. Return on Assets

Shows how efficient Capricor is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • -15.9% Return on Assets means that Capricor generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Capricor Therapeutics Inc:

  • The MRQ is -15.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-15.6%-0.3%
TTM-15.6%YOY-13.6%-2.0%
TTM-15.6%5Y-13.1%-2.4%
5Y-13.1%10Y-15.9%+2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-11.5%-4.4%
TTM-15.6%-11.6%-4.0%
YOY-13.6%-11.4%-2.2%
3Y-14.2%-11.8%-2.4%
5Y-13.1%-12.1%-1.0%
10Y-15.9%-13.8%-2.1%
4.3.1.3. Return on Equity

Shows how efficient Capricor is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • -19.1% Return on Equity means Capricor generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Capricor Therapeutics Inc:

  • The MRQ is -19.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -34.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.1%TTM-34.5%+15.4%
TTM-34.5%YOY-81.6%+47.1%
TTM-34.5%5Y-43.2%+8.7%
5Y-43.2%10Y-306.9%+263.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.1%-13.6%-5.5%
TTM-34.5%-14.9%-19.6%
YOY-81.6%-14.4%-67.2%
3Y-61.2%-17.0%-44.2%
5Y-43.2%-17.9%-25.3%
10Y-306.9%-20.1%-286.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Capricor Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Capricor is operating .

  • Measures how much profit Capricor makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Capricor Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-234.1%+234.1%
TTM-234.1%YOY-132.1%-101.9%
TTM-234.1%5Y-2,777.9%+2,543.9%
5Y-2,777.9%10Y-1,671.1%-1,106.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-234.1%-250.3%+16.2%
YOY-132.1%-205.1%+73.0%
3Y-248.8%-220.2%-28.6%
5Y-2,777.9%-342.6%-2,435.3%
10Y-1,671.1%-475.5%-1,195.6%
4.3.2.2. Operating Ratio

Measures how efficient Capricor is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-246.590+246.590
TTM-246.590YOY2.372-248.962
TTM-246.5905Y-6.630-239.960
5Y-6.63010Y3.527-10.157
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-246.5902.704-249.294
YOY2.3723.063-0.691
3Y-79.6503.576-83.226
5Y-6.6304.713-11.343
10Y3.5276.512-2.985
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Capricor Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Capricor is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.55 means the company has $6.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 6.548. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.970. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.548TTM4.970+1.577
TTM4.970YOY1.300+3.670
TTM4.9705Y6.444-1.474
5Y6.44410Y5.882+0.562
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5483.661+2.887
TTM4.9703.786+1.184
YOY1.3004.121-2.821
3Y2.7414.680-1.939
5Y6.4445.765+0.679
10Y5.8826.150-0.268
4.4.3.2. Quick Ratio

Measures if Capricor is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Quick Ratio of 11.68 means the company can pay off $11.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 11.677. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.301. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.677TTM8.301+3.375
TTM8.301YOY2.138+6.163
TTM8.3015Y7.507+0.794
5Y7.50710Y7.359+0.149
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6772.826+8.851
TTM8.3013.128+5.173
YOY2.1383.782-1.644
3Y4.5984.304+0.294
5Y7.5075.703+1.804
10Y7.3596.454+0.905
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Capricor Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Capricor assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Capricor to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that Capricor assets are financed with 17.0% credit (debt) and the remaining percentage (100% - 17.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 0.170. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.320. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.320-0.151
TTM0.320YOY0.808-0.487
TTM0.3205Y0.469-0.149
5Y0.46910Y0.636-0.167
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1700.324-0.154
TTM0.3200.347-0.027
YOY0.8080.327+0.481
3Y0.6290.339+0.290
5Y0.4690.349+0.120
10Y0.6360.382+0.254
4.5.4.2. Debt to Equity Ratio

Measures if Capricor is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Debt to Equity ratio of 20.5% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 0.205. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.767. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.767-0.562
TTM0.767YOY4.782-4.015
TTM0.7675Y2.041-1.275
5Y2.04110Y14.008-11.967
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2050.383-0.178
TTM0.7670.436+0.331
YOY4.7820.410+4.372
3Y3.1430.446+2.697
5Y2.0410.460+1.581
10Y14.0080.509+13.499
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Capricor generates.

  • Above 15 is considered overpriced but always compare Capricor to the Biotechnology industry mean.
  • A PE ratio of -4.45 means the investor is paying $-4.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Capricor Therapeutics Inc:

  • The EOD is -4.802. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.446. Based on the earnings, the company is expensive. -2
  • The TTM is -11.350. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.802MRQ-4.446-0.356
MRQ-4.446TTM-11.350+6.904
TTM-11.350YOY-23.696+12.346
TTM-11.3505Y-12.656+1.306
5Y-12.65610Y-10.708-1.948
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.802-2.197-2.605
MRQ-4.446-2.027-2.419
TTM-11.350-2.527-8.823
YOY-23.696-3.733-19.963
3Y-14.039-3.717-10.322
5Y-12.656-6.036-6.620
10Y-10.708-6.649-4.059
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Capricor Therapeutics Inc:

  • The EOD is -15.465. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.318. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.933. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.465MRQ-14.318-1.147
MRQ-14.318TTM-10.933-3.385
TTM-10.933YOY-13.621+2.688
TTM-10.9335Y-10.202-0.731
5Y-10.20210Y-9.998-0.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.465-3.007-12.458
MRQ-14.318-2.704-11.614
TTM-10.933-3.627-7.306
YOY-13.621-4.334-9.287
3Y-8.887-5.070-3.817
5Y-10.202-8.532-1.670
10Y-9.998-9.305-0.693
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Capricor is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.40 means the investor is paying $3.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Capricor Therapeutics Inc:

  • The EOD is 3.670. Based on the equity, the company is fair priced.
  • The MRQ is 3.398. Based on the equity, the company is fair priced.
  • The TTM is 9.218. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.670MRQ3.398+0.272
MRQ3.398TTM9.218-5.820
TTM9.218YOY4.819+4.399
TTM9.2185Y8.856+0.362
5Y8.85610Y78.327-69.470
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.6701.921+1.749
MRQ3.3981.843+1.555
TTM9.2182.113+7.105
YOY4.8192.467+2.352
3Y10.7082.541+8.167
5Y8.8563.666+5.190
10Y78.3274.311+74.016
4.6.2. Total Gains per Share

2.4. Latest News of Capricor Therapeutics Inc

Does Capricor Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Capricor Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-20
20:01
Google, Eli Lilly dip amid Friday's market cap stock moversRead
2025-06-20
18:09
Capricor falls after long-term trial data for Duchenne therapyRead
2025-06-16
13:27
H.C. Wainwright reaffirms Capricor stock rating amid FDA meeting notice withdrawalRead
2025-06-11
17:12
Capricor falls after facility inspection related to deramiocelRead
2025-06-11
15:25
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy ProgramRead
2025-06-06
18:12
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. - CAPRRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Capricor Therapeutics Inc.

4.8.1. Institutions holding Capricor Therapeutics Inc

Institutions are holding 40.967% of the shares of Capricor Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc6.44240.00062944665-22249-0.7499
2025-03-31Vanguard Group Inc4.95320.00042263991-12793-0.5619
2025-03-31Farallon Capital Management, L.L.C.4.92340.1191225040000
2025-03-31State Street Corp4.03170.00071842800-365568-16.5538
2025-03-31Geode Capital Management, LLC1.9720.0007901379219112.4914
2025-03-31Morgan Stanley - Brokerage Accounts1.78390.000681536518361129.0637
2025-03-31Woodline Partners LP1.59560.0457293189938415.7769
2025-03-31Citadel Advisors Llc0.910.000841595115070956.8194
2025-03-31Goldman Sachs Group Inc0.89950.000641114111637339.4795
2025-03-31Northern Trust Corp0.83090.0005379773-4384-1.1412
2025-03-31Pier Capital, LLC0.77490.56323541813541810
2025-03-31Black Diamond Financial, LLC0.60760.395827773700
2025-03-31SUPERSTRING CAPITAL MANAGEMENT LP0.52772.7233241192185963336.7126
2025-03-31Avidity Partners Management LP0.52290.43232390002390000
2025-03-31Millennium Management LLC0.48580.001122207010642892.0323
2025-03-31Squarepoint Ops LLC0.37460.002171213144226534.4277
2024-12-31Nuveen Asset Management, LLC0.370.0007169111134791392.7477
2025-03-31Susquehanna International Group, LLP0.36970.0003168988-112314-39.9265
2025-03-31Jump Financial LLC0.35670.02131630211630210
2025-03-31Kennedy Capital Management Inc0.33580.034815348792376.4035
Total 33.06834.343815114783+1391527+9.2%

4.9.2. Funds holding Capricor Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.70080.00091234475441993.7133
2025-05-31SPDR® S&P Biotech ETF2.08920.201395490956420.5944
2025-05-31iShares Russell 2000 ETF1.99220.014691058300
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.44280.00826594829920.1506
2025-03-31Fidelity Small Cap Index0.80240.014436676024860.6825
2025-05-31iShares Russell 2000 Growth ETF0.57980.023726500800
2025-04-30Fidelity Extended Market Index0.50280.0081229813-2196-0.9465
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.49690.005522713400
2025-04-30Vanguard Russell 2000 ETF0.39960.0196182631101995.9148
2025-04-30JPM Thematics Genetic Thrps C2 dist USD0.39860.63581821751821750
2025-03-31Pier Capital Small Cap Growth Equity0.320.54321462854017037.8552
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.2870.01513120000
2025-05-31SEB Nordamerikafond Småbolag0.28190.577412885572575.968
2025-03-31Kennedy Micro Cap0.23140.2116105787-382-0.3598
2025-04-30Schwab Small Cap Index0.19770.01979038000
2025-03-31NT R2000 Index Fund - NL0.19380.0144885874330.4912
2025-03-31Extended Equity Market Fund K0.18870.0062862362640.3071
2025-05-29Direxion Daily S&P Biotech Bull 3X ETF0.18570.140984879-2076-2.3874
2025-04-30Fidelity Total Market Index0.17210.0017867500
2025-05-31iShares Micro-Cap ETF0.1630.09517452200
Total 13.62642.55666228376+289163+4.6%

5.3. Insider Transactions

Insiders are holding 16.797% of the shares of Capricor Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-09-20Shinyaku Co Ltd NipponBUY27985075.36
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets153,766
Total Liabilities26,121
Total Stockholder Equity127,645
 As reported
Total Liabilities 26,121
Total Stockholder Equity+ 127,645
Total Assets = 153,766

Assets

Total Assets153,766
Total Current Assets146,251
Long-term Assets7,515
Total Current Assets
Cash And Cash Equivalents 28,795
Short-term Investments 115,983
Net Receivables 60
Other Current Assets 1,414
Total Current Assets  (as reported)146,251
Total Current Assets  (calculated)146,251
+/-0
Long-term Assets
Property Plant Equipment 7,262
Long-term Assets Other 253
Long-term Assets  (as reported)7,515
Long-term Assets  (calculated)7,515
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities22,337
Long-term Liabilities3,784
Total Stockholder Equity127,645
Total Current Liabilities
Short-term Debt 842
Accounts payable 5,254
Other Current Liabilities 4,241
Total Current Liabilities  (as reported)22,337
Total Current Liabilities  (calculated)10,337
+/- 12,000
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt407
Long-term Liabilities Other 3,376
Long-term Liabilities  (as reported)3,784
Long-term Liabilities  (calculated)3,784
+/-0
Total Stockholder Equity
Common Stock46
Retained Earnings -224,226
Accumulated Other Comprehensive Income 1,812
Other Stockholders Equity 350,014
Total Stockholder Equity (as reported)127,645
Total Stockholder Equity (calculated)127,645
+/-0
Other
Capital Stock46
Cash and Short Term Investments 144,777
Common Stock Shares Outstanding 45,637
Current Deferred Revenue12,000
Liabilities and Stockholders Equity 153,766
Net Debt -27,545
Net Invested Capital 127,645
Net Working Capital 123,914
Property Plant and Equipment Gross 10,933
Short Long Term Debt Total 1,249



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-31
> Total Assets 
0
0
0
0
6
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,623
17,089
14,487
11,190
8,409
6,435
4,263
2,254
4,829
3,620
2,372
5,872
4,809
3,666
2,418
3,704
3,091
1,372
716
1,000
495
227
415
295
114
5,538
15,977
18,437
16,283
13,632
27,471
23,691
19,882
16,070
16,985
13,892
24,472
18,747
14,068
14,218
15,794
16,274
15,388
14,327
12,233
9,247
8,618
7,307
7,907
11,114
14,294
37,126
36,187
34,619
43,544
39,930
43,101
41,330
64,922
58,066
53,928
50,095
53,863
46,011
37,152
58,734
49,444
38,277
92,952
170,481
153,766
153,766170,48192,95238,27749,44458,73437,15246,01153,86350,09553,92858,06664,92241,33043,10139,93043,54434,61936,18737,12614,29411,1147,9077,3078,6189,24712,23314,32715,38816,27415,79414,21814,06818,74724,47213,89216,98516,07019,88223,69127,47113,63216,28318,43715,9775,5381142954152274951,0007161,3723,0913,7042,4183,6664,8095,8722,3723,6204,8292,2544,2636,4358,40911,19014,48717,08918,62300401003031149100000060000
   > Total Current Assets 
0
0
0
0
6
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,408
16,760
14,044
10,764
8,005
6,046
3,946
1,956
4,556
3,433
2,296
5,801
4,740
3,597
2,352
3,640
3,028
1,310
656
942
438
172
404
289
109
3,681
14,031
16,410
14,196
11,608
25,420
21,643
17,714
13,990
14,890
11,809
22,404
18,108
13,465
13,640
15,232
15,713
14,613
13,541
11,393
8,471
7,904
6,643
7,291
10,545
13,770
36,253
35,491
33,677
41,880
38,731
41,298
36,437
59,634
52,624
47,505
42,889
46,595
38,925
29,527
50,855
41,412
30,669
85,823
163,385
146,251
146,251163,38585,82330,66941,41250,85529,52738,92546,59542,88947,50552,62459,63436,43741,29838,73141,88033,67735,49136,25313,77010,5457,2916,6437,9048,47111,39313,54114,61315,71315,23213,64013,46518,10822,40411,80914,89013,99017,71421,64325,42011,60814,19616,41014,0313,6811092894041724389426561,3103,0283,6402,3523,5974,7405,8012,2963,4334,5561,9563,9466,0468,00510,76414,04416,76018,40800401003031149100000060000
       Cash And Cash Equivalents 
0
0
0
0
6
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,039
16,233
13,660
10,348
7,364
5,501
3,607
1,770
4,224
3,176
2,013
5,563
4,436
3,378
2,124
3,260
2,607
1,039
436
777
283
47
285
229
71
1,730
12,979
11,582
9,805
8,035
6,939
20,533
17,218
5,568
11,766
8,851
20,521
16,195
2,750
8,261
8,897
6,140
7,169
6,339
4,378
4,259
7,170
5,891
6,828
3,899
13,217
36,253
35,300
32,666
41,880
38,078
40,839
34,885
58,334
16,394
8,414
9,603
10,606
9,837
8,985
14,695
6,215
10,688
68,377
11,287
28,795
28,79511,28768,37710,6886,21514,6958,9859,83710,6069,6038,41416,39458,33434,88540,83938,07841,88032,66635,30036,25313,2173,8996,8285,8917,1704,2594,3786,3397,1696,1408,8978,2612,75016,19520,5218,85111,7665,56817,21820,5336,9398,0359,80511,58212,9791,73071229285472837774361,0392,6073,2602,1243,3784,4365,5632,0133,1764,2241,7703,6075,5017,36410,34813,66016,23318,03900401003031149100000060000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,193
2,721
1,620
326
326
326
325
2,977
15,484
15,494
12,999
7,999
2,498
2,500
2,500
12,991
8,993
3,999
4,998
7,985
5,995
5,995
5,994
2,997
2,997
0
0
5,986
5,986
0
0
0
0
0
0
0
0
35,023
38,200
31,818
34,566
27,956
19,537
24,793
33,702
18,774
16,651
140,229
115,983
115,983140,22916,65118,77433,70224,79319,53727,95634,56631,81838,20035,023000000005,9865,986002,9972,9975,9945,9955,9957,9854,9983,9998,99312,9912,5002,5002,4987,99912,99915,49415,4842,9773253263263261,6202,7214,193000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
792
0
0
0
1
0
261
360
746
380
403
212
304
218
1,163
223
197
313
537
345
307
287
173
205
123
144
101
88
119
50
17
56
0
0
180
392
357
548
548
548
548
548
548
10,372
369
370
410
10,368
60
6010,36841037036910,37254854854854854854835739218000561750119881011441232051732873073455373131972231,16321830421240338074636026101000792000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
369
526
385
416
641
545
339
185
332
258
283
237
304
219
228
380
421
271
220
165
156
125
119
60
38
1,625
725
4,501
3,805
236
2,251
131
92
211
321
239
118
343
398
1,068
800
1,243
1,142
920
848
1,010
611
608
362
571
434
250
174
1,011
736
653
279
1,160
943
659
344
920
875
584
458
996
1,126
837
385
1,501
1,414
1,4141,5013858371,1269964585848759203446599431,1602796537361,0111742504345713626086111,0108489201,1421,2438001,068398343118239321211921312,2512363,8054,5017251,625386011912515616522027142138022821930423728325833218533954564141638552636900000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
330
443
426
404
390
317
298
273
186
75
72
69
69
67
65
63
62
60
58
57
55
11
6
5
1,857
1,946
2,028
2,087
2,025
2,051
2,048
2,169
2,080
2,095
2,083
2,067
639
603
578
561
561
775
786
840
776
713
664
617
569
524
873
696
942
1,665
1,199
1,802
4,893
5,288
5,442
6,423
7,206
7,269
7,086
7,625
7,879
8,033
7,608
7,128
7,096
7,515
7,5157,0967,1287,6088,0337,8797,6257,0867,2697,2066,4235,4425,2884,8931,8021,1991,6659426968735245696176647137768407867755615615786036392,0672,0832,0952,0802,1692,0482,0512,0252,0872,0281,9461,857561155575860626365676969727518627329831739040442644333021500000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
63
88
86
80
74
66
60
32
27
23
20
17
17
15
13
11
10
8
6
5
3
1
1
1
74
164
204
225
229
254
263
332
319
345
355
352
435
412
399
394
372
535
507
622
574
542
507
475
443
411
487
604
851
839
1,110
1,514
4,618
5,012
5,174
6,155
6,938
7,001
6,818
7,357
7,611
7,739
7,289
6,809
6,874
7,262
7,2626,8746,8097,2897,7397,6117,3576,8187,0016,9386,1555,1745,0124,6181,5141,11083985160448741144347550754257462250753537239439941243535235534531933226325422922520416474111356810111315171720232732606674808688635800000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000002000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
253
236
234
218
210
144
131
133
107
107
0
0
0
0
0
0
0
0
0
0
0
178
199
212
1,757
1,728
1,749
1,788
1,740
1,728
1,715
1,703
1,691
1,679
1,667
1,654
142
130
118
106
93
82
71,410
61
50
39
28
17,314
6,495
5,413
4,330
3
2
1,083
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,083234,3305,4136,49517,3142839506171,41082931061181301421,6541,6671,6791,6911,7031,7151,7281,7401,7881,7491,7281,7572121991780000000000010710713313114421021823423625312700000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52
52
0
52
0
0
0
0
0
0
1,783
1,782
1,824
1,862
1,795
1,797
1,785
1,836
1,761
1,750
1,728
1,716
204
191
179
168
189
158
207
157
152
133
129
125
120
107
82
89
89
89
89
289
276
276
58,066
0
268
0
-45,965,187
0
0
0
0
-92,858,661
78,357
0
078,357-92,858,6610000-45,965,1870268058,06627627628989898989821071201251291331521572071581891681791912041,7161,7281,7501,7611,8361,7851,7971,7951,8621,8241,7821,783000000520525200000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
9
9
12
21
25
28
35
35
42
52
50
50
59
67
67
74
78
83
90
125
135
145
168
1,357
1,889
1,379
1,000
918
1,332
778
440
845
638
889
1,150
1,505
1,069
744
436
718
541
485
458
468
394
1,058
1,528
1,682
6,073
17,636
21,522
20,755
19,881
20,147
19,136
17,957
17,101
18,068
19,008
24,423
22,751
21,260
20,805
20,064
5,047
4,854
4,696
5,252
4,631
4,877
4,943
4,337
4,274
4,701
5,472
5,779
6,419
7,164
6,550
6,365
9,962
40,279
39,337
38,502
38,309
47,657
43,280
38,940
36,133
31,010
26,775
24,687
25,019
26,121
26,12125,01924,68726,77531,01036,13338,94043,28047,65738,30938,50239,33740,2799,9626,3656,5507,1646,4195,7795,4724,7014,2744,3374,9434,8774,6315,2524,6964,8545,04720,06420,80521,26022,75124,42319,00818,06817,10117,95719,13620,14719,88120,75521,52217,6366,0731,6821,5281,0583944684584855417184367441,0691,5051,1508896388454407781,3329181,0001,3791,8891,357168145135125908378746767595050524235352825211299000
   > Total Current Liabilities 
0
0
0
9
9
12
21
25
28
35
35
42
52
50
50
59
67
67
74
78
83
90
125
135
145
168
1,357
1,889
1,311
1,000
918
1,332
778
440
845
638
889
1,150
1,505
1,069
744
436
718
541
485
267
287
331
649
1,016
1,182
2,053
6,299
6,492
6,192
6,300
7,545
6,863
6,534
6,529
7,341
6,205
6,670
4,895
3,299
16,644
16,688
1,671
1,478
1,320
1,876
1,255
1,501
1,567
961
898
1,325
1,918
2,278
2,971
3,752
3,174
2,988
4,133
14,323
19,547
23,195
23,587
37,132
35,154
32,927
31,270
26,384
22,355
20,476
21,026
22,337
22,33721,02620,47622,35526,38431,27032,92735,15437,13223,58723,19519,54714,3234,1332,9883,1743,7522,9712,2781,9181,3258989611,5671,5011,2551,8761,3201,4781,67116,68816,6443,2994,8956,6706,2057,3416,5296,5346,8637,5456,3006,1926,4926,2992,0531,1821,0166493312872674855417184367441,0691,5051,1508896388454407781,3329181,0001,3111,8891,357168145135125908378746767595050524235352825211299000
       Short-term Debt 
0
0
0
0
0
2
6
8
12
29
32
37
47
47
48
52
62
63
69
69
75
77
125
125
132
166
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191
259
327
0
0
0
0
9,156
0
2,734
1,823
9,156
0
0
699
13,906
13,906
14,156
14,156
0
0
0
0
0
0
0
0
0
0
140
193
247
283
16
32
418
498
580
698
682
694
707
730
749
772
793
814
835
842
8428358147937727497307076946826985804984183216283247193140000000000014,15614,15613,90613,906699009,1561,8232,73409,15600003272591910000000000000000000000166132125125777569696362524847473732291286200000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,156
0
0
0
9,156
0
0
0
13,906
13,906
14,156
14,156
0
0
0
0
0
0
0
0
0
0
140
193
247
283
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000283247193140000000000014,15614,15613,90613,9060009,1560009,1560000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
8
9
8
9
9
5
3
5
5
3
3
7
5
4
5
8
8
13
0
9
11
0
573
659
816
696
559
746
456
281
306
151
165
154
592
332
479
238
504
541
327
122
287
331
249
398
339
1,629
1,519
1,683
1,613
1,699
2,746
2,679
2,309
2,531
3,224
2,924
3,920
3,039
2,506
2,177
1,264
1,671
1,478
1,320
1,876
1,255
1,463
1,521
961
898
1,306
1,778
2,085
2,725
3,469
2,782
2,459
3,116
3,524
3,128
3,937
4,835
5,426
5,115
-6,785,158
6,223
6,239
6,160
0
0
5,254
5,254006,1606,2396,223-6,785,1585,1155,4264,8353,9373,1283,5243,1162,4592,7823,4692,7252,0851,7781,3068989611,5211,4631,2551,8761,3201,4781,6711,2642,1772,5063,0393,9202,9243,2242,5312,3092,6792,7461,6991,6131,6831,5191,6293393982493312871223275415042384793325921541651513062814567465596968166595730119013885457335535998980000
       Other Current Liabilities 
0
0
0
0
1
1
7
7
7
1
1
0
0
0
0
0
0
0
0
0
0
0
124,843
1
2
2
784
1,231
495
304
360
586
322
160
539
487
725
996
913
737
265
199
213
0
158
145
0
0
209
359
516
424
614
642
413
434
633
539
580
352
471
547
3,920
489
110
311
1,268
174
70
114
132
100
1,501
1,567
13
12
1,325
1,778
2,277,960
2,971,282
3,469
3,174
2,988
3,716
4,098
94
3,937
89
5,426
5,134
6,792
27
6,249
6,170
6,531
8,191
4,241
4,2418,1916,5316,1706,249276,7925,1345,426893,937944,0983,7162,9883,1743,4692,971,2822,277,9601,7781,32512131,5671,501100132114701741,2683111104893,9205474713525805396334344136426144245163592090014515802131992657379139967254875391603225863603044951,231784221124,8430000000000011777110000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191
181
63
409
512
500
4,020
11,337
15,030
14,562
13,581
12,601
12,272
11,422
10,573
10,727
12,804
17,752
17,855
17,961
4,160
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,554
3,501
3,448
3,412
3,376
3,376
5,829
25,956
19,789
15,307
14,722
10,525
8,126
6,013
4,863
4,626
4,420
4,211
3,993
3,784
3,7843,9934,2114,4204,6264,8636,0138,12610,52514,72215,30719,78925,9565,8293,3763,3763,4123,4483,5013,5543,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3764,16017,96117,85517,75212,80410,72710,57311,42212,27212,60113,58114,56215,03011,3374,020500512409631811910000000000000000680000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,642
9,156
9,156
9,156
9,156
9,156
9,156
10,156
12,156
17,006
17,006
17,006
0
0
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,554
3,501
3,448
3,412
3,376
0
3,376
0
3,376
3,376
3,376
3,376
3,376
0
0
0
0
0
0
0
00000003,3763,3763,3763,3763,37603,37603,3763,4123,4483,5013,5543,3763,3763,3763,3763,3763,3763,3763,3763,3763,3760017,00617,00617,00612,15610,1569,1569,1569,1569,1569,1569,1568,64200000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
7,375
6,388
5,407
4,426
3,444
3,116
2,267
1,417
571
647
3,847
3,949
4,055
4,160
3,377
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
23,650
17,631
0
12,844
0
6,608
0
0
0
0
0
0
0
00000006,608012,844017,63123,6503,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3774,1604,0553,9493,8476475711,4172,2673,1163,4444,4265,4076,3887,37558000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,250
5,208
4,167
3,125
2,734
1,823
911
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000009111,8232,7343,1254,1675,2086,25000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
-3
-12
-21
-25
-28
-35
-35
-41
-43
-46
-49
-59
-64
-67
-71
-78
-83
-90
-125
-135
-145
-168
17,266
15,200
13,108
10,190
7,491
5,104
3,484
1,814
3,984
2,982
1,483
4,723
3,304
2,597
1,674
3,268
2,373
831
231
542
27
-167
-643
-1,233
-1,568
-535
-1,659
-3,085
-4,472
-6,249
7,325
4,555
1,926
-1,032
-1,083
-5,116
49
-4,003
-7,192
-6,586
-4,271
11,227
10,534
9,631
6,980
4,616
3,740
2,364
3,570
6,839
9,593
31,654
30,408
28,200
36,381
33,380
36,736
31,368
24,643
18,729
15,426
11,786
6,206
2,731
-1,788
22,601
18,435
11,502
68,265
145,462
127,645
127,645145,46268,26511,50218,43522,601-1,7882,7316,20611,78615,42618,72924,64331,36836,73633,38036,38128,20030,40831,6549,5936,8393,5702,3643,7404,6166,9809,63110,53411,227-4,271-6,586-7,192-4,00349-5,116-1,083-1,0321,9264,5557,325-6,249-4,472-3,085-1,659-535-1,568-1,233-643-167275422318312,3733,2681,6742,5973,3044,7231,4832,9823,9841,8143,4845,1047,49110,19013,10815,20017,266-168-145-135-125-90-83-78-71-67-64-59-49-46-43-41-35-35-28-25-21-12-30000
   Common Stock
0
0
0
0
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
1
1
24
24
24
24
24
24
24
24
27
27
27
35
35
35
35
40
40
40
40
43
43
43
43
43
44
12
12
12
12
12
16
16
16
16
18
18
21
21
21
23
25
26
28
30
31
3
34
3
4
5
9
20
20
21
23
23
24
24
24
24
25
25
25
26
26
31
32
32
40
46
46
4646403232312626252525242424242323212020954334331302826252321212118181616161612121212124443434343434040404035353535272727242424242424242411888888888888888888880000
   Retained Earnings Total Equity0000000-152,215-144,848-137,080-129,359-122,9880-108,0600-97,938-93,190-88,038-83,860-79,950-76,466-74,381-72,911-71,305-69,258-66,739-63,479-59,343-55,219-51,548-63,853-61,118-57,646-53,979-49,461-44,128-39,439-35,172-31,826-28,914-25,791-22,315-20,387-18,843-17,309-16,099-48,137-47,788-47,191-46,708-46,506-45,940-45,587-44,815-43,151-42,00700000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8
-14
-14
-14
-14
-34
-34
0
0
-39
-39
0
0
-52
-52
0
0
-41
-41
0
0
-47
-22
-33
-3
-1
0
-1
-2
-112
-4
7
12
9
3
5
1
4
10
7
9
12
20
18
20
12
-489
-518
0
-1
-611
-642
-678
0
0
0
0
0
0
23
122
105
95
180
113
236
308
155
96
1,027
1,812
1,8121,027961553082361131809510512223000000-678-642-611-10-518-4891220182012971041539127-4-112-2-10-1-3-33-22-4700-41-4100-52-5200-39-3900-34-34-14-14-14-14-800000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,235
45,484
45,606
45,778
46,439
46,490
46,498
46,505
46,512
46,526
15,553
15,638
15,748
15,905
16,055
33,104
33,447
33,724
34,115
38,335
38,989
49,488
49,951
50,423
54,502
59,549
62,737
65,705
68,925
70,409
71,311
72,965
73,665
76,478
81,216
86,049
111,584
114,248
116,217
129,548
131,295
0
139,404
0
141,670
144,638
148,735
150,934
154,740
0
0
0
0
0
0
0
0000000154,740150,934148,735144,638141,6700139,4040131,295129,548116,217114,248111,58486,04981,21676,47873,66572,96571,31170,40968,92565,70562,73759,54954,50250,42349,95149,48838,98938,33534,11533,72433,44733,10416,05515,90515,74815,63815,55346,52646,51246,50546,49846,49046,43945,77845,60645,48445,23500000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
45
47
47
47
54
54
27,620
28,071
29,038
29,897
30,518
31,106
31,265
32,095
36,290
36,854
37,286
42,013
42,404
42,492
42,766
45,235
45,484
0
45,778
46,439
0
0
46,505
46,512
46,526
15,553
15,638
15,748
15,905
16,055
33,104
33,447
33,724
34,115
38,335
38,989
49,488
49,951
50,423
54,502
59,549
62,737
65,705
68,925
70,409
71,339
72,965
73,665
76,478
81,216
86,049
111,584
114,248
116,217
129,548
131,295
138,582
139,404
140,497
141,670
144,638
148,735
150,934
154,740
156,679
181,702
187,257
191,477
260,846
344,224
350,014
350,014344,224260,846191,477187,257181,702156,679154,740150,934148,735144,638141,670140,497139,404138,582131,295129,548116,217114,248111,58486,04981,21676,47873,66572,96571,33970,40968,92565,70562,73759,54954,50250,42349,95149,48838,98938,33534,11533,72433,44733,10416,05515,90515,74815,63815,55346,52646,51246,5050046,43945,778045,48445,23542,76642,49242,40442,01337,28636,85436,29032,09531,26531,10630,51829,89729,03828,07127,620545447474745434343434343434343434343434343430000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,270
Cost of Revenue-1,425
Gross Profit20,84520,845
 
Operating Income (+$)
Gross Profit20,845
Operating Expense-63,410
Operating Income-42,565-42,565
 
Operating Expense (+$)
Research Development49,969
Selling General Administrative14,215
Selling And Marketing Expenses0
Operating Expense63,41064,184
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-42,565
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-40,467-44,663
EBIT - interestExpense = -42,565
-40,467
-40,467
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-42,565-40,467
Earnings Before Interest and Taxes (EBITDA)-41,140
 
After tax Income (+$)
Income Before Tax-40,467
Tax Provision-0
Net Income From Continuing Ops-40,467-40,467
Net Income-40,467
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses64,835
Total Other Income/Expenses Net2,0980
 

Technical Analysis of Capricor
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Capricor. The general trend of Capricor is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Capricor's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Capricor Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Capricor Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.75 < 15.00 < 16.17.

The bearish price targets are: 6.5336 > 6.27 > 6.15.

Know someone who trades $CAPR? Share this with them.👇

Capricor Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Capricor Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Capricor Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Capricor Therapeutics Inc. The current macd is -0.31908306.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Capricor price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Capricor. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Capricor price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Capricor Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCapricor Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Capricor Therapeutics Inc. The current adx is 15.97.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Capricor shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Capricor Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Capricor Therapeutics Inc. The current sar is 10.78.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Capricor Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Capricor Therapeutics Inc. The current rsi is 47.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Capricor Therapeutics Inc Daily Relative Strength Index (RSI) ChartCapricor Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Capricor Therapeutics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Capricor price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Capricor Therapeutics Inc Daily Stochastic Oscillator ChartCapricor Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Capricor Therapeutics Inc. The current cci is -39.27699896.

Capricor Therapeutics Inc Daily Commodity Channel Index (CCI) ChartCapricor Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Capricor Therapeutics Inc. The current cmo is -4.50448975.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Capricor Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartCapricor Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Capricor Therapeutics Inc. The current willr is -45.92496766.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Capricor is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Capricor Therapeutics Inc Daily Williams %R ChartCapricor Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Capricor Therapeutics Inc.

Capricor Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Capricor Therapeutics Inc. The current atr is 1.32533739.

Capricor Therapeutics Inc Daily Average True Range (ATR) ChartCapricor Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Capricor Therapeutics Inc. The current obv is 90,594,644.

Capricor Therapeutics Inc Daily On-Balance Volume (OBV) ChartCapricor Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Capricor Therapeutics Inc. The current mfi is 42.78.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Capricor Therapeutics Inc Daily Money Flow Index (MFI) ChartCapricor Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Capricor Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Capricor Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Capricor Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.851
Ma 20Greater thanMa 5011.326
Ma 50Greater thanMa 10010.719
Ma 100Greater thanMa 20011.606
OpenGreater thanClose10.140
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Capricor with someone you think should read this too:
  • Are you bullish or bearish on Capricor? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Capricor? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Capricor Therapeutics Inc

I send you an email if I find something interesting about Capricor Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Capricor Therapeutics Inc.

Receive notifications about Capricor Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.